A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of AZD9898

NCT03140072 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

34

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated based on interim review

Conditions

Asthma

Interventions

DRUG: AZD9898
DRUG: Matching Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]